Community perks,
exclusive to you
Sponsor Perks
Fenwick
Fenwick is pleased to present the following package to the startups that are part of the Nucleate’s Activator Program (each one, a “Company”), inquire today. 1. Deferral. Through Nucleate’s expanded partnership with Fenwick, eligible Activator teams can access legal support earlier in the company-building process, including deferred billing and initial intellectual property advice. Explore the benefits below or inquire about support for your team. 2. Board Meetings. We will not charge for our attendance at routine board meetings while the Company is privately held and backed by venture capital or private equity financing. We do charge for travel expenses incurred for non-local meetings that you request we attend in person. 3. Client Intake. We will provide up to 10 hours free new client intake if company already formed. 4. Initial Intellectual Property advice. We will not charge for our time, up to a value of $3k, to provide initial advice on IP issues related to patent filing and prosecution strategy, licensing agreements, IP ownership and assignment, and freedom to operate risk analysis. Additionally, we will offer a further deferral of fees of up to $10k related to drafting and filing the first provisional patent application.
Fedsprout
Fedsprout is a premier consulting firm specializing in SBIR/STTR funding, commercialization, and award management for life science startups. They provide expert guidance on securing non-dilutive funding, crafting winning proposals, ensuring compliance with federal regulations, and navigating commercialization pathways within the SBIR/STTR program. With a proven track record of writing hundreds of proposals and supporting awardees, Fedsprout helps innovators bring cutting-edge therapeutics, diagnostics, and medical devices to market seamlessly. As part of this partnership, teams affiliated with Nucleate are eligible for a significant discount on Fedsprout services. To learn more about eligibility and available support, please contact ashah@fedsprout.com.
Mercury
As part of its partnership with Nucleate, Mercury offers exclusive perks to Nucleate community members, including a $500 sign-up bonus, discounts on lab space and other partner services, and free 409A valuations. Learn more about Mercury’s platform, open an account, or connect with their team through the Nucleate partnership link.
Community Perks
HiTE™
HiTE™ is a transduction enhancement technology developed by Nucleate alumni, designed to address one of the biggest bottlenecks in cell and gene therapy manufacturing: low and inconsistent viral transduction efficiency. HiTE™ uses a novel class of Transient Fusion-Promoting Peptides (TFPs) to enhance transduction across primary T cells (63%), iPSCs (73.9%), and NK cells (33.3%) representing 4–47× improvements over standard enhancers while maintaining >90% cell viability and enabling a 5–10× reduction in viral vector usage. The technology is drop-in compatible with existing workflows: no spinoculation, no plate coating, and under 8 hours from start to finish. HiTE™ is currently available for research use. Learn more at our website, white paper, or connect on LinkedIn.
Forage Evolution Plasmid Subcloning Kit
Forage Evolution is helping scientists spend less time at the bench and more time on the science—starting with the new Forager-Fast Plasmid Subcloning Kit, just launched by an NY alum–founded team. It’s the first competent cell on the market that does the plasmid transformation for you and grows super fast, so you can get to purified plasmid a full day (or two) sooner with far fewer hands-on steps. Want to try it out? Check it out here, and for the Nucleate community (please keep this to participants and alums so we can keep it active!) use promo code NUCLEATE-10 for 10% off.
Wasteless Bio
As early-stage biotech companies navigate lab setup and operations, access to equipment remains a key factor in managing both costs and timelines. Wasteless Bio is a marketplace for surplus life science equipment and consumables, designed to provide organizations with access to pre-owned instrumentation through a structured, vetted resale model that aims to address considerations around quality, compliance, and reliability. For more information, visit wasteless.bio or learn more here.
Novalix
Novalix and OpenBench have partnered to offer a fee-for-success drug-discovery model that helps early-stage life sciences companies access AI-powered virtual screening and experimental validation while reducing upfront financial risk. Learn more here.
Mentor Young Women in STEM
Nucleate is partnering with The Community Bots to connect Spanish-speaking women across our community with secondary school students at the MIR School for Girls in the Dominican Republic. Mentors will share their career journeys, encouragement, and perspectives on STEM through short asynchronous video messages, with a flexible commitment of just 1–2 hours per month from October 2026 to May 2027. No specific STEM background is required, and platform training is provided. Learn more or register to become a mentor!
SBIR/STTR eligibility & SBIR Planning tool
If you're focused on securing SBIR funding, the SBIR/STTR eligibility tool is worth checking out, helping you quickly confirm whether your company and project qualify before you invest time in a proposal. If you're on the fence between a Direct to Phase II vs. FastTrack, or would benefit from calendaring your upcoming proposal writing timeline, the SBIR Planning tool can help map out your submission strategy well ahead of deadlines.
Mercury networking events
Heading to HLTH 2026 in Las Vegas? Mercury is hosting two networking events bringing together healthcare innovators, investors, health system leaders, and industry partners. Join ScaleHealth, powered by CHIME x Mercury, for the HLTH Kickoff on November 15 from 4:00–6:00 PM at RedTail Sports Bar, Resorts World Las Vegas, to connect and exchange perspectives on healthcare’s most pressing challenges. On November 16 from 5:30–7:30 PM, DLA Piper x Mercury will host a cocktail reception at CHICA Las Vegas to discuss the regulatory, policy, and business developments shaping healthcare and life sciences. Space is limited. Contact health@mercury.com for registration details.
Jobs and Opportunities
Amplify Partners
Applications are now open for an Associate to join the bio investing team at Amplify Partners. Following the close of a $200M dedicated digital biology fund, Amplify is doubling down on founders building at the intersection of AI and life sciences. The team is looking for someone with a background in CS, AI, or computational biology who’s excited to go deep on research, build meaningful relationships across the bio x AI ecosystem, and work directly on deals from day one. This SF-based role offers high autonomy and the opportunity to help back the next generation of techbio founders. Interested? Reach out directly to david@amplifypartners.com
Marigold Biosciences
Marigold Biosciences is building the AI engine to unlock the full potential of programmable medicine. siRNA-based medicines are safe, clinically proven, and make it possible to design new drugs in days instead of decades. But they currently suffer from a last-mile problem: we can get siRNA to the liver, but it can't reach 95% of the body's tissues. Marigold generates proprietary, large-scale in vivo data and trains AI models to design peptides that deliver RNA to any tissue in the body. We are looking for talented and driven scientists to help build the biological data generation engine that fuels our AI models: designing experimental protocols, identifying tissue and disease targets, and managing internal and external discovery. Ideal candidates should have experience in oligonucleotide delivery, peptide design, or highly multiplexed in vivo screening. Joining offers the chance to build a category-defining platform from the ground up, significant equity ownership, and the autonomy to shape the scientific direction of the company. Roles open include Founding Scientist and Head of Biology.
Olden Labs
Almost all animal research is still done by hand, with methods dating to the 1960s, and only about 30% of studies replicate. Olden turns an ordinary cage into an automated platform that captures 20 biomarkers of health continuously and reproducibly. Our technology is used by major academic, government, and industry programs, and our first customer paper passed 100,000 views. Be the first in-house scientist at Olden. You’ll run the animal studies that build and validate entirely new measurements of health, cognition, strength, vision, hearing and more, and turn them into products used by labs worldwide. Why you’ll love this: (1) You build new science, not the same assay for the hundredth time. You design and validate brand-new automated measurements and watch them ship. (2) Your work gets seen. You’ll be an author on the papers it produces, and our science travels (our first customer paper passed 100k views). (3) You grow instead of narrowing. You work across biology, hardware, and AI/computer-vision, side by side with the engineers building the tech. (4) First scientist hire: early, high-ownership, and you shape how Olden does science as it scales. (5) The science you want to do, at 10x speed, without the red tape, grant cycles or the decade-long wait to find out if it mattered. Who it’s for: hands-on mouse experience, a PhD, a finishing PhD or postdoc, or a strong MSc/BSc, in neuroscience, physiology, animal behavior, or a related field, who is rigorous, high-agency, and wants to build. This is an early, intense startup role, not a 9-to-5. On site in South San Francisco, Starting now, Apply today.
Build @ Deerfield
Build @ Deerfield is a five-week AI hackathon hosted by Deerfield Management and Out-Of-Pocket for early-stage teams building in healthcare and life sciences. Shared by Nucleate alum Chanseo Lee, the program welcomes projects in AI for drug discovery and therapeutics, clinical ML, biosecurity, and robotics. Selected teams receive an initial $10,000 grant, mentorship from the Deerfield community, and the opportunity to compete for additional funding and prizes at Demo Day in New York City on January 21, 2027. Teams can participate remotely, and both new ideas and existing startups are welcome. Applications close November 19, 2026. Learn more and apply.
Sanofi iDEA-TECH Awards
Sanofi is inviting academic researchers and early-stage startups to apply for the iDEA-TECH Awards North America 2026–2027, offering $150,000 to support one-year projects exploring emerging science and technologies across the therapeutic pipeline. Research areas span AI/ML and modeling, disease models, digital biomarkers, precision medicine, small-molecule discovery, biologics and delivery technologies, and vaccines and infectious diseases. Pre-proposals are due December 11, 2026. For questions, contact iDEA-TECH@sanofi.com with “NA” in the subject line. Learn more and apply.
The Voyager Lab
The Voyager Lab is a student-founded nonprofit offering girls and gender-expansive youth opportunities to explore biotech through hands-on research, experiential learning, and science entrepreneurship. With mentorship and leadership opportunities at every stage, the organization helps participants develop their scientific interests and explore how research can translate into new ideas and ventures. Learn more about getting involved.